The healthcare zone centers around Thumbay University Hospital Dubai, which launches in Phase One with specialized services including renal dialysis, cardiology, orthopedics, and rehabilitation.
The acquisition gives Lilly access to Orna’s innovative platform, which combines circular RNA (circRNA) with lipid nanoparticle-based therapies.
The expansion also aligns with the government’s National Cancer Plan for England, which focuses on accelerating patient diagnosis and improving access to treatment nationwide.
The new San Diego facility will function as a critical node in Novartis’s integrated global research network, connecting seamlessly with existing research hubs in Basel, Switzerland, and Cambridge, Massachusetts.
GE HealthCare will join more than 4,300 exhibitors from over 180 countries at this gathering of leading innovators, suppliers, and healthcare professionals.
The new infrastructure enables the organization to procure, store, and rapidly deploy critical medical supplies when outbreaks threaten African communities.
Once fully operational, the manufacturing plant is expected to create direct employment opportunities for more than 500 people.
Hetronifly is an anti-programmed cell death protein 1 (PD-1) monoclonal antibody that has already received regulatory approval in China for treating several solid tumor types.
Once the transaction successfully closes, the combined company plans to operate under the PrimeGen US name or through a successor entity.
Within the context of AI and automation, these leaders anticipate emerging technologies, design future workflows, and guide laboratories toward digital maturity through strategic vision.